ERC Advanced Grant to Uppsala life science researcher

6 April 2018

The European Research Council (ERC) has announced the recipients of a total of EUR 653 million in the 2017 call for ERC Advanced Grants. At Uppsala University, Professor Carl-Henrik Heldin will receive a grant for a life science research project.

Carl-Henrik Heldin. Photo: Mikael Wallerstedt

Carl-Henrik Heldin is Professor at the Department of Medical Biochemistry and Microbiology and chair of the Nobel Foundation and SciLifeLab. His research team studies molecular mechanisms for growth regulation in normal and malignant cells. He will receive an Advanced Grant for his project “Pro-tumorigenic effects of TGFb – elucidation of mechanisms and development of selective inhibitors”.

The ERC’s Advanced Grants go to established and world-leading researchers. It consists of up to EUR 3.5 million spread out over a five-year period. The purpose of the grant is to give researchers the chance to realise their most creative ideas which could potentially result in discoveries with major impacts on science, society and economics in Europe.

In total, 2,167 researchers across Europe applied for Advanced Grants in the 2017 call, which is part of the EU’s research and innovation programme Horizon 2020. 269 researchers from 27 countries have been awarded grants. The greatest number of grants went to the United Kingdom (66), Germany (42) and France (34). Ten grants were awarded to Swedish higher education institutions.

Carl-Henrik Heldin’s research team

The European Research Council’s press release